Personal Information
Organización/Lugar de trabajo
Basel Area, Switzerland Switzerland
Ocupación
Biologist MSc - Sales Manager at Celonic (Biologics, Biosimilars, Cell Line Development, GMP biomanufacturing)
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
www.celonic.com
Acerca de
Celonic’s royalty-free mammalian CHO platform recently showed productivities more than 7 gr/L for monoclonal antibodies! With integrated and multi-disciplinary approach we can help you optimize your production processes to make your projects even more profitable.
Celonic AG creates powerful solutions well-tailored to your specific requirements:
• Excellent production mammalian cell line development from gene up to GMP manufacturing
(monoclonal Antibodies, fusion proteins, cytokines, blood coagulation factors and other
recombinant proteins).
• License already developed Biosimilar Cell Lines ( Bevacizumab, Adalimumab and other).
• State of the art single-use GMP capabilities up...
Etiquetas
cell lines
antibodies
biosimilars
cell culture
biologics
proteins
gmp
pharmaceutical
biotech
biotechnology
cancer
Ver más
Documentos
(6)Recomendaciones
(2)Concept Of Key Account Management
Ravi Ayilavarapu
•
Hace 14 años
Biosimilars report
George J Syrmalis
•
Hace 12 años
Personal Information
Organización/Lugar de trabajo
Basel Area, Switzerland Switzerland
Ocupación
Biologist MSc - Sales Manager at Celonic (Biologics, Biosimilars, Cell Line Development, GMP biomanufacturing)
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
www.celonic.com
Acerca de
Celonic’s royalty-free mammalian CHO platform recently showed productivities more than 7 gr/L for monoclonal antibodies! With integrated and multi-disciplinary approach we can help you optimize your production processes to make your projects even more profitable.
Celonic AG creates powerful solutions well-tailored to your specific requirements:
• Excellent production mammalian cell line development from gene up to GMP manufacturing
(monoclonal Antibodies, fusion proteins, cytokines, blood coagulation factors and other
recombinant proteins).
• License already developed Biosimilar Cell Lines ( Bevacizumab, Adalimumab and other).
• State of the art single-use GMP capabilities up...
Etiquetas
cell lines
antibodies
biosimilars
cell culture
biologics
proteins
gmp
pharmaceutical
biotech
biotechnology
cancer
Ver más